Renzhi Cai

Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin

Attila Nagy, Andrew V. Schally, Gábor Halmos et al. · Proceedings of the National Academy of Sciences · 1998 · 144 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Evaluation of Receptors for Somatostatin in Various Tumors Using Different Analogs*

Gordan Srkalović, Renzhi Cai, Andrew V. Schally · The Journal of Clinical Endocrinology & Metabolism · 1990 · 114 citations

Medicine, Oncology, Pharmacology +12

Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities

Renzhi Cai, Andrew V. Schally, Tengjiao Cui et al. · Peptides · 2013 · 84 citations · Full text

Life Sciences, Endocrinology, Pharmacology +13

Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1–STAT3/NF-κB signaling

Jinfeng Gan, Xiurong Ke, Jiali Jiang et al. · Proceedings of the National Academy of Sciences · 2016 · 79 citations · Full text

Medicine, Oncology, Pharmacology +17

Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters.

Károly Szepesházi, Andrew V. Schally, Renzhi Cai et al. · PubMed · 1991 · 72 citations

Medicine, Oncology, Pharmacology +15